Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Eli Lilly's weight-loss pill Foundayo meets its main goal in a late-stage trial by easing sleep apnea.
6 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly's weight-loss pill Foundayo meets its main goal in a late-stage trial by easing sleep apnea.
Eli Lilly has struck a deal allowing Hims & Hers Health to sell its obesity drugs Zepbound and Foundayo directly on its platform.
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly has introduced Foundayo, a new daily oral weight-loss medication, to the United Kingdom market, driving a significant rise in company stock.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.